Federal Judge Tosses PhRMA’s Suit on Medicare Drug Price Plan (1)

The Biden administration secured a major win Monday in its fight to uphold Medicare’s drug price negotiation program by persuading a federal judge to toss a lawsuit from the top group representing the brand-name prescription drug industry.

The US District Court for the Western District of Texas ruled it lacks jurisdiction over the National Infusion Center Association’s legal challenge to the negotiation program.

Given that the association was the only party residing in the district, the rest of the lawsuit—which includes the Pharmaceutical Research and Manufacturers of America, and the National Infusion Center Association and Global Colon Cancer Association—was likewise ...